Medical and Surgical Management of the Failed Pancreas Transplant

IF 1.9 Q3 TRANSPLANTATION
Michael J. Casey, N. Murakami, S. Ong, Joel T Adler, Neeraj Singh, Haris Murad, Sandesh Parajuli, Beatrice P. Concepcion, Michelle L. Lubetzky, M. Pavlakis, K. Woodside, Arman Faravardeh, A. Basu, E. Tantisattamo, A. Aala, Angelika G. Gruessner, D. Dadhania, K. Lentine, Matthew Cooper, Ronald F. Parsons, T. Alhamad
{"title":"Medical and Surgical Management of the Failed Pancreas Transplant","authors":"Michael J. Casey, N. Murakami, S. Ong, Joel T Adler, Neeraj Singh, Haris Murad, Sandesh Parajuli, Beatrice P. Concepcion, Michelle L. Lubetzky, M. Pavlakis, K. Woodside, Arman Faravardeh, A. Basu, E. Tantisattamo, A. Aala, Angelika G. Gruessner, D. Dadhania, K. Lentine, Matthew Cooper, Ronald F. Parsons, T. Alhamad","doi":"10.1097/TXD.0000000000001543","DOIUrl":null,"url":null,"abstract":"Despite the continued improvements in pancreas transplant outcomes in recent decades, a subset of recipients experience graft failure and can experience substantial morbidity and mortality. Here, we summarize what is known about the failed pancreas allograft and what factors are important for consideration of retransplantation. The current definition of pancreas allograft failure and its challenges for the transplant community are explored. The impacts of a failed pancreas allograft are presented, including patient survival and resultant morbidities. The signs, symptoms, and medical and surgical management of a failed pancreas allograft are described, whereas the options and consequences of immunosuppression withdrawal are reviewed. Medical and surgical factors necessary for successful retransplant candidacy are detailed with emphasis on how well-selected patients may achieve excellent retransplant outcomes. To achieve substantial medical mitigation and even pancreas retransplantation, patients with a failed pancreas allograft warrant special attention to their residual renal, cardiovascular, and pulmonary function. Future studies of the failed pancreas allograft will require improved reporting of graft failure from transplant centers and continued investigation from experienced centers.","PeriodicalId":23225,"journal":{"name":"Transplantation Direct","volume":"28 12","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation Direct","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/TXD.0000000000001543","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"TRANSPLANTATION","Score":null,"Total":0}
引用次数: 0

Abstract

Despite the continued improvements in pancreas transplant outcomes in recent decades, a subset of recipients experience graft failure and can experience substantial morbidity and mortality. Here, we summarize what is known about the failed pancreas allograft and what factors are important for consideration of retransplantation. The current definition of pancreas allograft failure and its challenges for the transplant community are explored. The impacts of a failed pancreas allograft are presented, including patient survival and resultant morbidities. The signs, symptoms, and medical and surgical management of a failed pancreas allograft are described, whereas the options and consequences of immunosuppression withdrawal are reviewed. Medical and surgical factors necessary for successful retransplant candidacy are detailed with emphasis on how well-selected patients may achieve excellent retransplant outcomes. To achieve substantial medical mitigation and even pancreas retransplantation, patients with a failed pancreas allograft warrant special attention to their residual renal, cardiovascular, and pulmonary function. Future studies of the failed pancreas allograft will require improved reporting of graft failure from transplant centers and continued investigation from experienced centers.
胰腺移植失败的内外科治疗
尽管近几十年来胰腺移植的结果不断改善,但一小部分受者经历了移植失败,并可能经历大量的发病率和死亡率。在这里,我们总结了关于胰腺移植失败的已知情况以及考虑再次移植的重要因素。目前胰脏移植失败的定义及其对移植界的挑战进行了探讨。胰腺异体移植失败的影响,包括患者生存和由此产生的发病率。异体胰腺移植失败的体征、症状、医疗和外科治疗被描述,而免疫抑制退出的选择和后果被审查。对成功的再移植候选资格所必需的医学和外科因素进行了详细介绍,重点是如何精心选择患者才能获得良好的再移植结果。为了实现实质性的医疗缓解甚至胰腺再移植,移植胰腺失败的患者需要特别注意其残余的肾脏、心血管和肺功能。未来对同种异体胰腺移植失败的研究将需要移植中心改进移植失败的报告,并需要有经验的中心继续进行调查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Transplantation Direct
Transplantation Direct TRANSPLANTATION-
CiteScore
3.40
自引率
4.30%
发文量
193
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信